Cargando…

Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model

Cardiovascular diseases form the most common cause of death worldwide, with atherosclerosis as main etiology. Atherosclerosis is marked by cholesterol rich lipoprotein deposition in the artery wall, evoking a pathogenic immune response. Characteristic for the disease is the pathogenic accumulation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaftenaar, Frank H., Amersfoort, Jacob, Douna, Hidde, Kröner, Mara J., Foks, Amanda C., Bot, Ilze, Slütter, Bram A., van Puijvelde, Gijs H. M., Drijfhout, Jan W., Kuiper, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874568/ https://www.ncbi.nlm.nih.gov/pubmed/31757993 http://dx.doi.org/10.1038/s41598-019-53642-z

Ejemplares similares

Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis
por: Amersfoort, Jacob, et al.
Publicado: (2018)

IFNγ-Stimulated B Cells Inhibit T Follicular Helper Cells and Protect Against Atherosclerosis
por: Douna, Hidde, et al.
Publicado: (2022)

Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells
por: Amersfoort, Jacob, et al.
Publicado: (2020)

Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
por: Kritikou, Eva, et al.
Publicado: (2016)

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE(-/-) mice
por: Dunér, Pontus, et al.
Publicado: (2021)

Identification of apoB‐100 Peptide‐Specific CD8+ T Cells in Atherosclerosis
por: Dimayuga, Paul C., et al.
Publicado: (2017)

Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
por: Foks, Amanda C., et al.
Publicado: (2013)

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR(−/−) Mouse Strain
por: Lantos, Ildikó, et al.
Publicado: (2018)

Tc17 CD8(+) T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development
por: van Duijn, Janine, et al.
Publicado: (2020)

T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis
por: Shaw, Michael K., et al.
Publicado: (2017)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

Flow Cytometry-Based Characterization of Mast Cells in Human Atherosclerosis
por: Kritikou, Eva, et al.
Publicado: (2019)

ApoB-Specific CD4(+) T Cells in Mouse and Human Atherosclerosis
por: Marchini, Timoteo, et al.
Publicado: (2021)

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013)

Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice
por: Choe, Moon Kyung, et al.
Publicado: (2021)

Western Diet Decreases Hepatic Drug Metabolism in Male LDLr(−/−)ApoB(100/100) Mice
por: Koponen, Markus, et al.
Publicado: (2023)

Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque
por: Egusa, Genshi
Publicado: (2021)

Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization
por: van Ingen, Eva, et al.
Publicado: (2019)

Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022)

CD8(+) T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide
por: Chyu, Kuang-Yuh, et al.
Publicado: (2012)

Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice
por: Lénárt, Nikolett, et al.
Publicado: (2012)

Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice
por: Tóth, Melinda E., et al.
Publicado: (2020)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker
por: Hurt-Camejo, Eva, et al.
Publicado: (2018)

ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage
por: Ramírez, Carlos, et al.
Publicado: (2011)

Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets
por: Suzuki, Michitaka, et al.
Publicado: (2012)

Subjects with Molecularly Defined Familial Hypercholesterolemia or Familial Defective apoB-100 Are Not Being Adequately Treated
por: Leren, Trond P., et al.
Publicado: (2011)

Roles of ApoB-100 Gene Polymorphisms and the Risks of Gallstones and Gallbladder Cancer: A Meta-Analysis
por: Gong, Yi, et al.
Publicado: (2013)

Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes
por: Wei, Hong-Shan, et al.
Publicado: (2013)

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness
por: Ellenbroek, Guilielmus H.J.M., et al.
Publicado: (2017)

Mouse, but Not Human, ApoB-100 Lipoprotein Cholesterol Is a Potent Innate Inhibitor of Streptococcus pneumoniae Pneumolysin
por: Wade, Kristin R., et al.
Publicado: (2014)

Prevalence of ApoB100 rs693 gene polymorphism in metabolic syndrome among female students at King Abdulaziz University
por: Alghamdi, Rana A., et al.
Publicado: (2021)

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR(–/–)ApoB(100/100) mice
por: Blanco, Fabiana, et al.
Publicado: (2018)

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study
por: Walldius, Göran, et al.
Publicado: (2021)

ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels
por: Jun, Ji Eun, et al.
Publicado: (2018)

High ApoB/ApoA-I Ratio Predicts Post-Stroke Cognitive Impairment in Acute Ischemic Stroke Patients with Large Artery Atherosclerosis
por: Lee, Minwoo, et al.
Publicado: (2023)

CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice
por: van Puijvelde, Gijs H. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8q980nq0393aqqfjje29pfu4ro